Discontinuation report ACT NABILONE

Last updated on 2020-10-15 History
Report ID 126452
Drug Identification Number 02393581
Brand name ACT NABILONE
Common or Proper name ACT-NABILONE 0.5 MG CAPS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) NABILONE
Strength(s) 0.5MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100
ATC code A04AD
ATC description ANTIEMETICS AND ANTINAUSEANTS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2020-08-21
Actual discontinuation date 2020-08-21
Remaining supply date 2020-08-21
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Item Discontinued
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-10-15 French Compare
v1 2020-10-15 English Compare